Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gene therapy for blindness gets attention of investors
Crain's Detroit Business
Sunday, June 29, 2014 - 10:58am
tags:
RetroSense Therapeutics
How a secret sex tape plunged British drugs giant Glaxo into a £90million bribery probe
Daily Mail, UK
Sunday, June 29, 2014 - 10:51am
tags:
GSK, China, legal
Bitter Pill To Swallow: Can The US Market Bear The Cost Of Sovaldi?
Forbes
Sunday, June 29, 2014 - 10:25am
tags:
Sovaldi
AbbVie scuppers Shire bid for rival
The Telegraph, UK
Sunday, June 29, 2014 - 10:07am
tags:
AbbVie, Shire, NPS Pharmaceuticals, M&A
Courts weigh in on generic drug delays
PBS
Sunday, June 29, 2014 - 10:05am
tags:
lawsuits, generics
Is GlaxoSmithKline's Dividend Safe?
Motley Fool
Sunday, June 29, 2014 - 10:03am
tags:
GSK
3 Biotech Stocks with Jaw-Dropping Growth Potential
Motley Fool
Sunday, June 29, 2014 - 10:01am
tags:
Cubist Pharmaceuticals, NPS Pharmaceuticals, Flamel
Phase II Calamity Dooms Ohr's Eye Drops
Seeking Alpha
Sunday, June 29, 2014 - 10:00am
tags:
Squalamine Eye Drops, Ohr Pharmaceutical, macular degeneration, wet age-related macular degeneration
ZS Pharma begins enrollment in phase 3 study of ZS-9 in Hyperkalemia patients
Pharmabiz
Saturday, June 28, 2014 - 11:49am
tags:
hyperkalemia, ZS Pharma, ZS-9
FDA's generic-drug label rule draws controversy
Modern Healthcare
Saturday, June 28, 2014 - 11:42am
tags:
FDA, generics
Mesa company that tightens skin, targets fat bought for $600 million
AZ Central, AZ
Saturday, June 28, 2014 - 11:39am
tags:
Ulthera, devices
BioDelivery Progresses with Clonidine Late-Stage Study
Yahoo/Zacks
Saturday, June 28, 2014 - 10:35am
tags:
BioDelivery Sciences, diabetic neuropathy, clonidine topical gel
MannKind: No Surprises, Big Hit
Barron's
Saturday, June 28, 2014 - 10:33am
tags:
MannKind, inhaled insulin, Afrezza, diabetes
MannKind Wins U.S. FDA Approval for Inhaled Insulin
Bloomberg
Friday, June 27, 2014 - 5:30pm
tags:
MannKind, FDA, inhaled insulin, Afrezza, diabetes, insulin
CDC committee recommends AZ's FluMist over flu shot in children
Fierce Vaccines
Friday, June 27, 2014 - 11:12am
tags:
CDC, AstraZeneca, vaccines, flu vaccines, FluMist
Pacira's Exparel Positive in Phase IV Studies
Yahoo/Zacks.com
Friday, June 27, 2014 - 11:00am
tags:
EXPAREL, Pacira
BrainStorm Cell, Octane construct bioreactor prototype for NurOwn
Yahoo/Fly on the Wall
Friday, June 27, 2014 - 10:59am
tags:
BrainStorm Cell Therapeutics, Octane Biotech, NurOwn, stem cells
Shire chief hits the road, talking up an AbbVie-free future
Fierce Biotech
Friday, June 27, 2014 - 9:56am
tags:
AbbVie, M&A, Shire, Flemming Ornskov
Eli Lilly's anti-takeover superpower? A shield forged by Indiana lawmakers
Fierce Pharma
Friday, June 27, 2014 - 9:55am
tags:
Eli Lilly, Indiana, M&A
IPO Preview: GlobeImmune
Seeking Alpha
Friday, June 27, 2014 - 9:53am
tags:
IPOs, GlobeImmune, Tarmogen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.